Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC. 2017

Grazia Piizzi, and David T Parker, and Yunshan Peng, and Markus Dobler, and Anup Patnaik, and Som Wattanasin, and Eugene Liu, and Francois Lenoir, and Jill Nunez, and John Kerrigan, and David McKenney, and Colin Osborne, and Donghui Yu, and Leanne Lanieri, and Jade Bojkovic, and JoAnn Dzink-Fox, and Maria-Dawn Lilly, and Elizabeth R Sprague, and Yipin Lu, and Hongming Wang, and Srijan Ranjitkar, and Lili Xie, and Bing Wang, and Meir Glick, and Lawrence G Hamann, and Ruben Tommasi, and Xia Yang, and Charles R Dean

Over the past several decades, the frequency of antibacterial resistance in hospitals, including multidrug resistance (MDR) and its association with serious infectious diseases, has increased at alarming rates. Pseudomonas aeruginosa is a leading cause of nosocomial infections, and resistance to virtually all approved antibacterial agents is emerging in this pathogen. To address the need for new agents to treat MDR P. aeruginosa, we focused on inhibiting the first committed step in the biosynthesis of lipid A, the deacetylation of uridyldiphospho-3-O-(R-hydroxydecanoyl)-N-acetylglucosamine by the enzyme LpxC. We approached this through the design, synthesis, and biological evaluation of novel hydroxamic acid LpxC inhibitors, exemplified by 1, where cytotoxicity against mammalian cell lines was reduced, solubility and plasma-protein binding were improved while retaining potent anti-pseudomonal activity in vitro and in vivo.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000581 Amidohydrolases Any member of the class of enzymes that catalyze the cleavage of amide bonds and result in the addition of water to the resulting molecules. Amidases,Amidohydrolase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Grazia Piizzi, and David T Parker, and Yunshan Peng, and Markus Dobler, and Anup Patnaik, and Som Wattanasin, and Eugene Liu, and Francois Lenoir, and Jill Nunez, and John Kerrigan, and David McKenney, and Colin Osborne, and Donghui Yu, and Leanne Lanieri, and Jade Bojkovic, and JoAnn Dzink-Fox, and Maria-Dawn Lilly, and Elizabeth R Sprague, and Yipin Lu, and Hongming Wang, and Srijan Ranjitkar, and Lili Xie, and Bing Wang, and Meir Glick, and Lawrence G Hamann, and Ruben Tommasi, and Xia Yang, and Charles R Dean
July 2002, Journal of medicinal chemistry,
Grazia Piizzi, and David T Parker, and Yunshan Peng, and Markus Dobler, and Anup Patnaik, and Som Wattanasin, and Eugene Liu, and Francois Lenoir, and Jill Nunez, and John Kerrigan, and David McKenney, and Colin Osborne, and Donghui Yu, and Leanne Lanieri, and Jade Bojkovic, and JoAnn Dzink-Fox, and Maria-Dawn Lilly, and Elizabeth R Sprague, and Yipin Lu, and Hongming Wang, and Srijan Ranjitkar, and Lili Xie, and Bing Wang, and Meir Glick, and Lawrence G Hamann, and Ruben Tommasi, and Xia Yang, and Charles R Dean
January 2016, Current topics in medicinal chemistry,
Grazia Piizzi, and David T Parker, and Yunshan Peng, and Markus Dobler, and Anup Patnaik, and Som Wattanasin, and Eugene Liu, and Francois Lenoir, and Jill Nunez, and John Kerrigan, and David McKenney, and Colin Osborne, and Donghui Yu, and Leanne Lanieri, and Jade Bojkovic, and JoAnn Dzink-Fox, and Maria-Dawn Lilly, and Elizabeth R Sprague, and Yipin Lu, and Hongming Wang, and Srijan Ranjitkar, and Lili Xie, and Bing Wang, and Meir Glick, and Lawrence G Hamann, and Ruben Tommasi, and Xia Yang, and Charles R Dean
May 2007, Journal of medicinal chemistry,
Grazia Piizzi, and David T Parker, and Yunshan Peng, and Markus Dobler, and Anup Patnaik, and Som Wattanasin, and Eugene Liu, and Francois Lenoir, and Jill Nunez, and John Kerrigan, and David McKenney, and Colin Osborne, and Donghui Yu, and Leanne Lanieri, and Jade Bojkovic, and JoAnn Dzink-Fox, and Maria-Dawn Lilly, and Elizabeth R Sprague, and Yipin Lu, and Hongming Wang, and Srijan Ranjitkar, and Lili Xie, and Bing Wang, and Meir Glick, and Lawrence G Hamann, and Ruben Tommasi, and Xia Yang, and Charles R Dean
March 2008, Protein science : a publication of the Protein Society,
Grazia Piizzi, and David T Parker, and Yunshan Peng, and Markus Dobler, and Anup Patnaik, and Som Wattanasin, and Eugene Liu, and Francois Lenoir, and Jill Nunez, and John Kerrigan, and David McKenney, and Colin Osborne, and Donghui Yu, and Leanne Lanieri, and Jade Bojkovic, and JoAnn Dzink-Fox, and Maria-Dawn Lilly, and Elizabeth R Sprague, and Yipin Lu, and Hongming Wang, and Srijan Ranjitkar, and Lili Xie, and Bing Wang, and Meir Glick, and Lawrence G Hamann, and Ruben Tommasi, and Xia Yang, and Charles R Dean
January 2008, Chemical biology & drug design,
Grazia Piizzi, and David T Parker, and Yunshan Peng, and Markus Dobler, and Anup Patnaik, and Som Wattanasin, and Eugene Liu, and Francois Lenoir, and Jill Nunez, and John Kerrigan, and David McKenney, and Colin Osborne, and Donghui Yu, and Leanne Lanieri, and Jade Bojkovic, and JoAnn Dzink-Fox, and Maria-Dawn Lilly, and Elizabeth R Sprague, and Yipin Lu, and Hongming Wang, and Srijan Ranjitkar, and Lili Xie, and Bing Wang, and Meir Glick, and Lawrence G Hamann, and Ruben Tommasi, and Xia Yang, and Charles R Dean
February 2007, Bioorganic & medicinal chemistry letters,
Grazia Piizzi, and David T Parker, and Yunshan Peng, and Markus Dobler, and Anup Patnaik, and Som Wattanasin, and Eugene Liu, and Francois Lenoir, and Jill Nunez, and John Kerrigan, and David McKenney, and Colin Osborne, and Donghui Yu, and Leanne Lanieri, and Jade Bojkovic, and JoAnn Dzink-Fox, and Maria-Dawn Lilly, and Elizabeth R Sprague, and Yipin Lu, and Hongming Wang, and Srijan Ranjitkar, and Lili Xie, and Bing Wang, and Meir Glick, and Lawrence G Hamann, and Ruben Tommasi, and Xia Yang, and Charles R Dean
February 2011, Bioorganic & medicinal chemistry letters,
Grazia Piizzi, and David T Parker, and Yunshan Peng, and Markus Dobler, and Anup Patnaik, and Som Wattanasin, and Eugene Liu, and Francois Lenoir, and Jill Nunez, and John Kerrigan, and David McKenney, and Colin Osborne, and Donghui Yu, and Leanne Lanieri, and Jade Bojkovic, and JoAnn Dzink-Fox, and Maria-Dawn Lilly, and Elizabeth R Sprague, and Yipin Lu, and Hongming Wang, and Srijan Ranjitkar, and Lili Xie, and Bing Wang, and Meir Glick, and Lawrence G Hamann, and Ruben Tommasi, and Xia Yang, and Charles R Dean
November 2019, Antimicrobial agents and chemotherapy,
Grazia Piizzi, and David T Parker, and Yunshan Peng, and Markus Dobler, and Anup Patnaik, and Som Wattanasin, and Eugene Liu, and Francois Lenoir, and Jill Nunez, and John Kerrigan, and David McKenney, and Colin Osborne, and Donghui Yu, and Leanne Lanieri, and Jade Bojkovic, and JoAnn Dzink-Fox, and Maria-Dawn Lilly, and Elizabeth R Sprague, and Yipin Lu, and Hongming Wang, and Srijan Ranjitkar, and Lili Xie, and Bing Wang, and Meir Glick, and Lawrence G Hamann, and Ruben Tommasi, and Xia Yang, and Charles R Dean
January 2007, Journal of chemical information and modeling,
Grazia Piizzi, and David T Parker, and Yunshan Peng, and Markus Dobler, and Anup Patnaik, and Som Wattanasin, and Eugene Liu, and Francois Lenoir, and Jill Nunez, and John Kerrigan, and David McKenney, and Colin Osborne, and Donghui Yu, and Leanne Lanieri, and Jade Bojkovic, and JoAnn Dzink-Fox, and Maria-Dawn Lilly, and Elizabeth R Sprague, and Yipin Lu, and Hongming Wang, and Srijan Ranjitkar, and Lili Xie, and Bing Wang, and Meir Glick, and Lawrence G Hamann, and Ruben Tommasi, and Xia Yang, and Charles R Dean
January 2007, Journal of chemical information and modeling,
Copied contents to your clipboard!